Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Mylan Gets FDA Final Approval For Generic Toprol-XL
Financial News Network
Saturday, December 17, 2011 - 11:38am
tags:
Mylan, generics, Toprol XL
3 Biotechs That Were Crushed This Week And Why
Seeking Alpha
Saturday, December 17, 2011 - 11:36am
tags:
Antares, BioSante, Inhibitex
ISTA Rejects Valeant's $314M Takeover Offer
WSJ
Saturday, December 17, 2011 - 11:34am
tags:
Ista, Valeant Pharmaceuticals, M&A
Checking Illumina's Growth
Motley Fool
Saturday, December 17, 2011 - 11:32am
tags:
Illumina
Safety (Still) Trumps Acquisitions in Hep C
Motley Fool
Saturday, December 17, 2011 - 11:31am
tags:
hepatitis C
InterMune Shares Plunged: What You Need to Know
Motley Fool
Saturday, December 17, 2011 - 11:30am
tags:
InterMune, idiopathic pulmonary fibrosis
Charles River Guides Higher
Yahoo/Zacks
Saturday, December 17, 2011 - 11:28am
tags:
Charles River Laboratories
Amgen rises after announcing retirement of CEO
Yahoo/AP
Saturday, December 17, 2011 - 11:27am
tags:
Amgen, Kevin Sharer
Inhibitex Shares Got Crushed: What You Need to Know
Motley Fool
Saturday, December 17, 2011 - 11:26am
tags:
Inhibitex, INX-189, PSI-938, hepatitis C
Pomerantz Reminds Shareholders of Human Genome Sciences, Inc. of Upcoming Deadline - HGSI
Yahoo/Globe NewsWire
Saturday, December 17, 2011 - 11:24am
tags:
Human Genome Sciences
Inhibitex, Idenix rattled by rival's drug failure
MarketWatch
Saturday, December 17, 2011 - 11:23am
tags:
Inhibitex, Idenix, PSI-938, Pharmasset, hepatitis C
Covidien Spins Off Drug Company: 5 Drug Makers Hedge Funds Want Most
Motley Fool
Saturday, December 17, 2011 - 11:21am
tags:
Covidien, Rigel Pharmaceuticals, Aegerion, Impax Laboratories, WuXi PharmaTech, Abbott Laboratories
Checking the Quality of Gilead's Growth
Motley Fool
Saturday, December 17, 2011 - 11:19am
tags:
Gilead Sciences
How The FDA Could Mitigate Drug Shortages
Pharmalot
Friday, December 16, 2011 - 12:05pm
tags:
FDA, drug shortages
Analyzing Pharmaceutical Strategic Alliances
Seeking Alpha
Friday, December 16, 2011 - 12:03pm
tags:
GSK, Pfizer, Lpath, Human Genome Sciences
Dendreon 2011: Supply Constrained to Missed Guidance
Motley Fool
Friday, December 16, 2011 - 11:31am
tags:
Dendreon, guidance, Provenge, prostate cancer
Hep C Drug Panic! Pharmasset Stumble Ripples Through Sector
TheStreet.com
Friday, December 16, 2011 - 11:29am
tags:
Pharmasset, hepatitis C, Gilead, Inhibitex, PSI-938, Indenix
Pharmasset Says Drug Trial Change Won’t Affect Gilead Takeover Agreement
Bloomberg
Friday, December 16, 2011 - 11:26am
tags:
Pharmasset, Gilead, M&A, hepatitis C, PSI-938
Pfizer reports positive Phase III drug trial in RLS
Marketwatch
Friday, December 16, 2011 - 10:33am
tags:
Pfizer, RLS, restless legs syndrome, Lyrica
Valeant Sets Its Sights on Another Takeover Target
WSJ Online
Friday, December 16, 2011 - 10:32am
tags:
Valeant Pharmaceuticals, M&A, ISTA Pharmaceuticals, eye health

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.